我們使用 Cookie 以允許我們網站的正常工作、個性化設計內容和廣告、提供社交媒體功能並分析流量。我們還同社交媒體、廣告和分析合作夥伴分享有關您使用我們網站的信息
Drug Products
Since establishing its injectable plant in 2013, ScinoPharm has implemented a vertical integration strategy for pharmaceuticals, encompassing the production and marketing of intermediates, active pharmaceutical ingredients (APIs), and finished products. Our company continues to strengthen its injectable product portfolio, expanding from its advanced API expertise into the development of finished drug formulations, with an emphasis on medications for oncology, hematology, metabolic disorders, and central nervous system diseases. Additionally, ScinoPharm has progressively entered the high-end complex injectable product sector in response to the growing market demand.